Global Custom Market Research Reports Provider Company

phone

Regen BioPharma Inc (RGBP) - Financial and Strategic SWOT Analysis Review

  • Published Date: 13 Nov 2017
  • Number of Pages: 25
  • Category: Healthcare and Medical
  • Country: United States of America
Summary

Regen BioPharma Inc (Regen BioPharma), a subsidiary of Bio-Matrix Scientific Group Inc is a biotechnology company that concentrates on the development of immunotherapies and cancer stem cell therapies. The companys product pipeline includes HemaXellerate, dCellVax, DiffronC, small molecule targeting cancer stem cell genes, telomeres and genomic integrity. It provides products for aplastic anemia, myelodysplastic syndrome, solid tumors and acute leukemia, breast cancer, hematopoiesis and liver cancer, among others. The company spans its expertise in the development of therapies including small molecules, stem cell treatments and the bodys own immune system. Regen BioPharma is headquartered in La Mesa, California, the US.

Regen BioPharma Inc Key Recent Developments

Oct 30,2017: Regen BioPharma Announces Former Eli Lilly Executive and Current CVS Board Member will Lead Newly Formed Business Advisory Board (BAB)
Oct 23,2017: Regen BioPharma Begins Program to Determine the 3-Dimensional Crystal Structure of NR2F6
Jul 12,2017: Regen BioPharma Researchers Discover New Dynamic Compound Which Modulates the NR2F6 Checkpoint
May 16,2017: Regen BioPharma Sees Additional Positive Results on its Medicinal Chemistry Optimization for Modulating NR2F6 Checkpoint for Treating Cancer and Autoimmune Diseases
Apr 18,2017: Regen BioPharma Identifies Three New Series of Compounds That Activate NR2F6

This comprehensive SWOT profile of Regen BioPharma Inc provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalDatas Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, GlobalDatas highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Regen BioPharma Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,



- Business description A detailed description of the companys operations and business divisions.

- Corporate strategy Analysts summarization of the companys business strategy.

- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.

- Company history Progression of key events associated with the company.

- Major products and services A list of major products, services and brands of the company.

- Key competitors A list of key competitors to the company.

- Key employees A list of the key executives of the company.

- Executive biographies A brief Summary of the executives employment history.

- Key operational heads A list of personnel heading key departments/functions.

- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.



Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,



You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.



Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.



Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.



Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.



Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Publisher Name : GlobalData
Table of Contents


Section 1 - About the Company



Regen BioPharma Inc - Key Information

Regen BioPharma Inc - Overview

Regen BioPharma Inc - Key Employees

Regen BioPharma Inc - Key Employee Biographies

Regen BioPharma Inc - Key Operational Heads

Regen BioPharma Inc - Major Products and Services

Regen BioPharma Inc - History

Regen BioPharma Inc - Company Statement

Regen BioPharma Inc - Locations And Subsidiaries

Regen BioPharma Inc - Key Manufacturing facilities

Head Office

Other Locations & Subsidiaries



Section 2 - Company Analysis



Regen BioPharma Inc - Business Description

Regen BioPharma Inc - Corporate Strategy

Regen BioPharma Inc - SWOT Analysis

SWOT Analysis - Overview

Regen BioPharma Inc - Strengths

Regen BioPharma Inc - Weaknesses

Regen BioPharma Inc - Opportunities

Regen BioPharma Inc - Threats

Regen BioPharma Inc - Key Competitors



Section 3 - Company Financial Performance Charts



Regen BioPharma Inc - Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts



Section 4 - Appendix



Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer





Note*: Some sections may be missing if data is unavailable for the company

List Of Tables




Regen BioPharma Inc, Key Information

Regen BioPharma Inc, Key Ratios

Regen BioPharma Inc, Share Data

Regen BioPharma Inc, Major Products and Services

Regen BioPharma Inc, History

Regen BioPharma Inc, Key Employees

Regen BioPharma Inc, Key Employee Biographies

Regen BioPharma Inc, Key Operational Heads

Regen BioPharma Inc, Other Locations

Regen BioPharma Inc, Subsidiaries

Regen BioPharma Inc, Key Manufacturing facilities

Regen BioPharma Inc, Key Competitors

Regen BioPharma Inc, SWOT Analysis

Regen BioPharma Inc, Ratios based on current share price

Regen BioPharma Inc, Annual Ratios

Regen BioPharma Inc, Interim Ratios

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List Of Figures




Regen BioPharma Inc, Performance Chart

Regen BioPharma Inc, Ratio Charts

In this report, the global Cartilage Regeneration Tchnology market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022,

View Report

RegeneRx Biopharmaceuticals Inc (RegeneRx) is a biopharmaceutical company that provides clinical stage drug development solutions. The company offers clinical trials, science and discovery and business development services. Its business development

View Report

Regenera Pharma Ltd (Regenera Pharma) is a pharmaceutical company that develops a novel drug for neurological indications. The companys product RPh201, a botanical drug developed to repair permanent damages caused

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports